ELEMIS Revenue and Competitors
Estimated Revenue & Valuation
- ELEMIS's estimated annual revenue is currently $75M per year.
- ELEMIS's estimated revenue per employee is $96,774
Employee Data
- ELEMIS has 775 Employees.
- ELEMIS grew their employee count by 76% last year.
ELEMIS's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Co-Founder and Global President | Reveal Email/Phone |
3 | Head Data & Analytics | Reveal Email/Phone |
4 | HEAD EXPORT | Reveal Email/Phone |
5 | Payroll Officer | Reveal Email/Phone |
6 | Head Omnichannel Marketing | Reveal Email/Phone |
7 | Head Retail UK | Reveal Email/Phone |
8 | VP, TV Shopping North America | Reveal Email/Phone |
9 | VP Digital Channels | Reveal Email/Phone |
10 | VP, Finance & Planning | Reveal Email/Phone |
ELEMIS Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $77.4M | 385 | 3% | N/A | N/A |
#2 | $34M | 226 | 20% | $19.8M | N/A |
#3 | $0.2M | 3 | -25% | N/A | N/A |
#4 | $35M | 331 | 10% | N/A | N/A |
What Is ELEMIS?
ELEMIS IS...\n\nThe #1 Luxury British Skincare Brand.\n\nYour skin, your body and your wellness lie at the heart of ELEMIS.\n\nEvery GROUND-BREAKING formula is an innovative blend of science with the chemistry of nature, carefully crafted by a dedicated team of explorers, scientists and skincare experts.\n\nEncompassing the most POWERFUL biological actives available from both 'above and below' the earth’s surface, ELEMIS’ meticulous attention to detail, pioneering formulas and remarkably transformative RESULTS are what truly sets our skincare apart.\n\nTHE ELEMIS ETHOS:\n\nPure Results\nPioneering products prescribed for individual skincare and lifestyle needs. SCIENTIFICALLY-PROVEN.\n\nSourced From Nature\nPowerful biological actives from above and below the earth’s surface, combined with intricately blended aromatics. HAND IN HAND.\n\nScientific Innovation\nHigh-performance formulations developed using cutting-edge science and technology. GROUND-BREAKING.\n\nEver Evolving\nAn unwavering commitment to understanding the relationship between nature and humanity. PERSONALISED.\n\nTHE POWER OF SCIENCE \n\nOur scientific objective has always been to provide skin and body care of the highest quality and efficacy. Blending superior botanicals and laboratory-made ingredients such as peptides and anti-oxidants, we create formulations that undergo meticulous clinical and consumer testing. We are dedicated to delivering products that visibly renew and enhance the appearance of skin, offering truly remarkable results.\n\nTHE POWER OF NATURE\n\nELEMIS is dedicated to exploring our global ecosystem and supporting its communities. Our plant-based botanicals are sourced from all corners of the globe. Chosen for their uniqueness, potency, dynamic properties and efficacy, our scientists expertly hand-blend these in development to produce revolutionary, cutting-edge formulas.
keywords:N/AN/A
Total Funding
775
Number of Employees
$75M
Revenue (est)
76%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ELEMIS News
For those unfamiliar, Elemis is an award-winning luxury British beauty brand that has won itself a devoted following. In fact, according to the...
Elemis' best-selling Pro-Collagen Hydra-Gel Eye Masks help to hydrate, smooth and tighten the delicate under-eye area (and, is especially great...
Shop the sale to save on everything from skincare brands like Elemis and Tarte to home goods from Vince Camuto, style finds from Dooney...
Skincare brand see personalization drive 7.02% uplift in RPV with just one experience [LONDON - 7 NOVEMBER 2018] - Elemis, the number one luxury British skincare brand, have renewed their partnership with Qubit and continue to make the customer experience through personalization a top priority ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $263.7M | 775 | N/A | N/A |
#2 | $35M | 776 | 6% | N/A |
#3 | $300M | 777 | N/A | N/A |
#4 | $293.7M | 777 | 8% | N/A |
#5 | $75M | 777 | 6% | N/A |